MAPT and Alzheimer disease: The tau protein in exosomes represents a promising strategy for diagnostic purposes, as full-length tau has been found to be more abundant in exosomes than in the free solutions of plasma or CSF of AD patients, whereas healthy individuals do not exhibit full-length tau [128].